Search
for
Sort by
Research 31–60 of 1000+
- Consequences of steroid-5α-reductase deficiency and inhibition in vertebrates
- The Impact of the 5α-Reductase Inhibitors (5α-RIs) on Male Sexual Function and Psychological Well-Being
- Skin and glucocorticoids: effects of local skin glucocorticoid impairment on skin homeostasis
- Synthesis and in Vitro Evaluation of 4-Substituted N-(1,1-Dimethylethyl)-3-oxo-4-androstene-17.beta.-carboxamides as 5.alpha.-Reductase Inhibitors and Antiandrogens
- 9 Role of 5α-reductase in health and disease
- Effect of Testosterone Supplementation With and Without a Dual 5α-Reductase Inhibitor on Fat-Free Mass in Men With Suppressed Testosterone Production
- 5-alpha reductase inhibitors: New evidences on benefits and harms beyond benign prostatic hyperplasia
- Generalised Glucocorticoid Resistance
- Glucocorticoid and Sex Hormone Receptors: Clinical Implications and Therapeutic Relevance
- Open-label placebos reduce hair cortisol concentrations and psychological distress - a randomized controlled trial
- Evidence for Increased 5α-Reductase Activity During Early Childhood in Daughters of Women With Polycystic Ovary Syndrome
- The antiandrogen enzalutamide downregulates TMPRSS2 and reduces cellular entry of SARS-CoV-2 in human lung cells
- Elastogenesis Stimulation by Minoxidil or Nebivolol Reduces Premature Aging of the Aortic Wall in Diabetic Mice
- Spironolactone, a Classic Potassium-Sparing Diuretic, Reduces Survivin Expression and Chemosensitizes Cancer Cells to Non-DNA-Damaging Anticancer Drugs
- Alcohol Exposure During Late Adolescence Increases Drinking in Adult Wistar Rats, an Effect that is not Reduced by Finasteride
- Treatment of androgen excess in females: Yesterday, today and tomorrow
- 5α-reductase activity in women with polycystic ovary syndrome: a systematic review and meta-analysis
- Physiopathological role of the enzymatic complex 5α-reductase and 3α/β-hydroxysteroid oxidoreductase in the generation of progesterone and testosterone neuroactive metabolites
- Adrenal Disorders and the Paediatric Brain: Pathophysiological Considerations and Clinical Implications
- Dermatological medications and local therapeutics
- Metabolic dysfunction in female mice with disruption of 5α-reductase 1
- Androgens and androgen receptor action in skin and hair follicles
- Clinical review 74: Dermatological manifestations of endocrine disorders.
- Dermatological drugs, topical agents, and cosmetics
- Idiopathic Hirsutism*
- Therapeutic strategies for treating hair loss
- Adverse cutaneous reactions to chemotherapeutic agents and cytokine therapy
- Steroid Biomarkers and Genetic Studies Reveal Inactivating Mutations in Hexose-6-Phosphate Dehydrogenase in Patients with Cortisone Reductase Deficiency
- Biological Profile of Cortexolone 17a-Propionate (CB-03-01), a New Topical and Peripherally Selective Androgen Antagonist
- Urinary steroid metabolome shows adrenal, gonadal, and neuroactive steroid dysregulation in adolescents with depression